Toggle navigation
Home
Search
Services
Blog
Contact
About
Task 4: The Interventional Agent Development Services program
Kneteman, Norman
Sri International, Menlo Park, CA, United States
Search 111 grants from Norman Kneteman
Search grants from Sri International
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Unraveling the therapeutic potential of a new class of splicing modulators
Highly specific, temporally controllable mouse genetic tools for investigating in
A novel recessive genetic screen for mitochondrial phenotypes in mammalian cells
Statins for Alzheimer's disease immunotherapy
Disentangling Disparities in Trauma and Mental Health Service Use
Recently added grants:
Relationships between parity, breastfeeding and ER- breast cancer in African American women: Elucidating the biologic underpinnings at the molecular and cellular level.
Glutamate receptor plasticity underlying incubation of methamphetamine craving
DOTA-based pre-targeting of alpha emitters
Role of HIV in acceleration of HPV malignancy
Targeting p38 gamma signaling to advance Cutaneous T Cell Lymphoma Therapy
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
272201100022I-0-27200004-2
Application #
8753161
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$789,733
Indirect Cost
Institution
Name
Sri International
Department
Type
DUNS #
009232752
City
Menlo Park
State
CA
Country
United States
Zip Code
94025
Related projects
NIH 2013
N01 AI
Task 4: The Interventional Agent Development Services program
Kneteman, Norman / Sri International
$789,733
NIH 2011
N01 AI
Task 4: Preclinical Services for the Development of Interventional Agents
Mirsalis, Jon / Sri International
$350,000
Comments
Be the first to comment on Norman Kneteman's grant